The Role of Technology in Adherence to Physical Activity Programs in Patients with Chronic Diseases Experiencing Fatigue: a Systematic Review.

Activity monitors COPD Cancer Guidelines Patients Pedometers Self-efficacy steps Technology Wearables

Journal

Sports medicine - open
ISSN: 2199-1170
Titre abrégé: Sports Med Open
Pays: Switzerland
ID NLM: 101662568

Informations de publication

Date de publication:
12 Sep 2019
Historique:
received: 23 01 2019
accepted: 19 08 2019
entrez: 13 9 2019
pubmed: 13 9 2019
medline: 13 9 2019
Statut: epublish

Résumé

The beneficial role of physical activity (PA) to manage the health condition of patients with chronic diseases is well known. However, adherence to PA guidelines in this group is still low. Monitoring and user-interface technology could represent a significant tool to increase exercise adherence to those particular groups who experience difficulties in adhering to regular and substantial physical activity, and could be supportive in increasing the success of PA programs and interventions. This systematic review aimed at evaluating the effect of physical activity monitoring technology in improving adherence to a PA program in patients with chronic diseases experiencing fatigue. This systematic review was conducted according to PRISMA guidelines. The literature search was performed in Embase, Medline, Biosis, Scopus, and SPORTDiscus. We filtered the literature according to the question: "Does monitoring technology affect adherence to physical activity and exercise programs in patients with chronic diseases perceiving fatigue?". The search resulted in 1790 hits; finally, eight studies were included, with a total number of 205 patients. Study quality was moderate except for one study of high quality. Only three disease types emerged, COPD, HF, and cancer. PA programs were rather short (from 8 to 13 weeks) except for one 3-year-long study. Five studies employed pedometers and two an activity monitor. Three studies based their adherence on steps, the remaining studies focused on active minutes. Adherence was explicitly reported in two studies, and otherwise derived. Four studies showed high adherence levels (85% week-10, 89% week-8, 81% week-13, 105% week-13, 83% average week-1-12) and three low levels (56% week-12, 41% year-2, 14 year-3). The small number of studies identified did not allow to establish whether the use of monitoring technology could improve adherence to PA programs in patients with chronic diseases experiencing fatigue, but the current evidence seems to suggest that this is a field warranting further study, particularly into how monitoring technology can help to engage patients to adhere to PA programs.

Sections du résumé

BACKGROUND BACKGROUND
The beneficial role of physical activity (PA) to manage the health condition of patients with chronic diseases is well known. However, adherence to PA guidelines in this group is still low. Monitoring and user-interface technology could represent a significant tool to increase exercise adherence to those particular groups who experience difficulties in adhering to regular and substantial physical activity, and could be supportive in increasing the success of PA programs and interventions. This systematic review aimed at evaluating the effect of physical activity monitoring technology in improving adherence to a PA program in patients with chronic diseases experiencing fatigue.
METHODS METHODS
This systematic review was conducted according to PRISMA guidelines. The literature search was performed in Embase, Medline, Biosis, Scopus, and SPORTDiscus. We filtered the literature according to the question: "Does monitoring technology affect adherence to physical activity and exercise programs in patients with chronic diseases perceiving fatigue?".
RESULTS RESULTS
The search resulted in 1790 hits; finally, eight studies were included, with a total number of 205 patients. Study quality was moderate except for one study of high quality. Only three disease types emerged, COPD, HF, and cancer. PA programs were rather short (from 8 to 13 weeks) except for one 3-year-long study. Five studies employed pedometers and two an activity monitor. Three studies based their adherence on steps, the remaining studies focused on active minutes. Adherence was explicitly reported in two studies, and otherwise derived. Four studies showed high adherence levels (85% week-10, 89% week-8, 81% week-13, 105% week-13, 83% average week-1-12) and three low levels (56% week-12, 41% year-2, 14 year-3).
CONCLUSION CONCLUSIONS
The small number of studies identified did not allow to establish whether the use of monitoring technology could improve adherence to PA programs in patients with chronic diseases experiencing fatigue, but the current evidence seems to suggest that this is a field warranting further study, particularly into how monitoring technology can help to engage patients to adhere to PA programs.

Identifiants

pubmed: 31512075
doi: 10.1186/s40798-019-0214-z
pii: 10.1186/s40798-019-0214-z
pmc: PMC6739434
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

41

Références

Curr Cardiol Rev. 2008 May;4(2):92-100
pubmed: 19936283
Prog Cardiovasc Dis. 2015 Jan-Feb;57(4):375-86
pubmed: 25459975
Atherosclerosis. 2014 Jul;235(1):150-61
pubmed: 24835434
J Am Coll Cardiol. 2019 Apr 2;73(12):1430-1443
pubmed: 30922474
Nat Rev Clin Oncol. 2014 Oct;11(10):597-609
pubmed: 25113839
Respir Med. 2012 Sep;106(9):1342-50
pubmed: 22795984
Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65
pubmed: 22878278
Acta Oncol. 2014 Apr;53(4):510-20
pubmed: 24460069
Cancer Med. 2016 May;5(5):787-94
pubmed: 26872005
Med Sci Sports Exerc. 2008 Jan;40(1):181-8
pubmed: 18091006
Ann Fam Med. 2008 Jan-Feb;6(1):69-77
pubmed: 18195317
J Epidemiol Community Health. 1998 Jun;52(6):377-84
pubmed: 9764259
Mhealth. 2017 Nov 27;3:51
pubmed: 29430455
Arch Phys Med Rehabil. 2019 Jul;100(7):1234-1242.e1
pubmed: 30620890
J Nephrol. 2017 Dec;30(6):729-741
pubmed: 28689231
BMC Med. 2014 Feb 27;12:36
pubmed: 24571580
Diabetes Ther. 2018 Aug;9(4):1421-1429
pubmed: 29869049
Med Sci Sports Exerc. 2014 Sep;46(9):1840-8
pubmed: 24777201
BMC Cancer. 2018 Nov 21;18(1):1151
pubmed: 30463615
Acta Diabetol. 2011 Sep;48(3):183-9
pubmed: 21431832
Am J Prev Med. 2011 Apr;40(4):454-61
pubmed: 21406280
Clin J Oncol Nurs. 2012 Jun 1;16(3):293-300
pubmed: 22641322
Health Informatics J. 2016 Sep;22(3):451-69
pubmed: 25649783
Psychooncology. 2009 Apr;18(4):369-76
pubmed: 19242921
Palliat Med. 2008 Jan;22(1):13-32
pubmed: 18216074
BMJ Open. 2015 Jan 29;5(1):e007591
pubmed: 25633288
Cardiovasc Diabetol. 2011 Jan 28;10:12
pubmed: 21276212
BMC Public Health. 2014 Apr 19;14:382
pubmed: 24745369
Oncol Nurs Forum. 2006 Jul 01;33(4):775-83
pubmed: 16858459
Perm J. 2015 Fall;19(4):84-8
pubmed: 26517440
BMC Med Inform Decis Mak. 2016 Feb 25;16:26
pubmed: 26911326
J Clin Epidemiol. 2009 Oct;62(10):e1-34
pubmed: 19631507
Eur Respir J. 2015 Feb;45(2):347-54
pubmed: 25261324
J Med Internet Res. 2016 Apr 04;18(4):e69
pubmed: 27044310
Prog Cardiovasc Nurs. 2008 Winter;23(1):12-7
pubmed: 18326992
Respir Med. 2015 Aug;109(8):1048-57
pubmed: 26070272
Eur J Epidemiol. 2015 Jul;30(7):529-42
pubmed: 26092138
Int J Telerehabil. 2016 Dec 15;8(2):39-48
pubmed: 28775800
J R Soc Med. 2006 Oct;99(10):506-20
pubmed: 17021301
J Med Internet Res. 2015 Nov 10;17(11):e253
pubmed: 26554314
Respir Care. 2018 Feb;63(2):131-140
pubmed: 29066590
JAMA. 2007 Nov 21;298(19):2296-304
pubmed: 18029834
Cancer Prev Res (Phila). 2013 Feb;6(2):109-18
pubmed: 23213072
Nutr Clin Pract. 2014 Dec;29(6):768-79
pubmed: 25335787
Man Ther. 2010 Jun;15(3):220-8
pubmed: 20163979
Arch Phys Med Rehabil. 2011 Sep;92(9):1371-81
pubmed: 21878207
J Psychosom Res. 2010 Jul;69(1):33-41
pubmed: 20630261
Psychiatr Serv. 2005 Mar;56(3):324-31
pubmed: 15746508
Int J Chron Obstruct Pulmon Dis. 2016 Feb 19;11 Spec Iss:13-20
pubmed: 26937186
Expert Rev Respir Med. 2010 Dec;4(6):735-45
pubmed: 21128749
Thorax. 2014 Aug;69(8):731-9
pubmed: 24558112
Spine J. 2013 Dec;13(12):1940-50
pubmed: 24169445
Ann Oncol. 2016 Sep;27(9):1761-7
pubmed: 27443634
Diabet Med. 2015 Aug;32(8):1058-62
pubmed: 25764343
Sports Med Open. 2018 Sep 3;4(1):42
pubmed: 30178072
Int J Exerc Sci. 2017 Jan 1;10(1):146-153
pubmed: 28479955
Transl Behav Med. 2013 Dec;3(4):402-5
pubmed: 24294328
Telemed J E Health. 2015 Oct;21(10):782-92
pubmed: 26431257
Curr Cardiol Rep. 2005 May;7(3):216-22
pubmed: 15865864
JMIR Mhealth Uhealth. 2016 Jun 23;4(2):e77
pubmed: 27339153
J Telemed Telecare. 2017 Jan;23(1):74-82
pubmed: 26888420
Prev Med Rep. 2016 Jun 08;4:209-19
pubmed: 27413684
Br J Sports Med. 2019 Mar;53(6):335-336
pubmed: 30366964
Scand J Med Sci Sports. 2015 Dec;25 Suppl 3:1-72
pubmed: 26606383
Disabil Rehabil. 2018 Nov 18;:1-10
pubmed: 30449204

Auteurs

Andrea Albergoni (A)

Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy.
Department of Patient Care & Measurements, Philips Research, Eindhoven, The Netherlands.

Florentina J Hettinga (FJ)

School of Sport Rehabilitation and Exercise Sciences, University of Essex, Colchester, UK.
Department of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle, UK.

Antonio La Torre (A)

Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy.
IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.

Matteo Bonato (M)

IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.

Francesco Sartor (F)

Department of Patient Care & Measurements, Philips Research, Eindhoven, The Netherlands. francesco.sartor@philips.com.
School of Sport Rehabilitation and Exercise Sciences, University of Essex, Colchester, UK. francesco.sartor@philips.com.
College of Health & Behavioural Science, Bangor University, Bangor, UK. francesco.sartor@philips.com.
Philips Electronics Nederland B.V, HTC 34 1.011, P.O. Box WB61, 5656, AE, Eindhoven, The Netherlands. francesco.sartor@philips.com.

Classifications MeSH